Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Feb;32(2):259–261. doi: 10.1128/aac.32.2.259

In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods.

G V Doern 1, T A Tubert 1
PMCID: PMC172147  PMID: 3129988

Abstract

The in vitro activities of 39 antimicrobial agents were assessed versus 74 clinical isolates of Branhamella catarrhalis. Resistance was observed only with penicillin and ampicillin and then only with beta-lactamase-producing strains. The results of in vitro susceptibility tests with agar dilution and broth microdilution procedures were found to be comparable. The results of broth tube macrodilution tests were, in general, one twofold-concentration increment higher.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Croughan M. J., Calder M. A. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrob Agents Chemother. 1984 Sep;26(3):424–425. doi: 10.1128/aac.26.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alvarez S., Jones M., Holtsclaw-Berk S., Guarderas J., Berk S. L. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doern G. V. Branhamella catarrhalis--an emerging human pathogen. Diagn Microbiol Infect Dis. 1986 Mar;4(3):191–201. doi: 10.1016/0732-8893(86)90098-2. [DOI] [PubMed] [Google Scholar]
  4. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doern G. V., Tubert T. A. Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays. J Clin Microbiol. 1987 Aug;25(8):1380–1383. doi: 10.1128/jcm.25.8.1380-1383.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doern G. V., Tubert T. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob Agents Chemother. 1987 Oct;31(10):1519–1523. doi: 10.1128/aac.31.10.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doern G. V., Tubert T. Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis. J Clin Microbiol. 1987 Aug;25(8):1576–1578. doi: 10.1128/jcm.25.8.1576-1578.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Farmer T., Reading C. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors. Drugs. 1986;31 (Suppl 3):70–78. doi: 10.2165/00003495-198600313-00015. [DOI] [PubMed] [Google Scholar]
  9. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sweeney K. G., Verghese A., Needham C. A. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother. 1985 Apr;27(4):499–502. doi: 10.1128/aac.27.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES